Adriamycin is an aminoglycosidic anthracycline antibiotic widely used in the treatment of cancer. Increasing reports point to the involvem ent o f cell membranes in its mechanism of action. The interaction of adriamycin with human erythrocytes was investigated in order to determine the membrane binding sites and the resultant structural perturbation. Electron microscopy revealed that red cells incubated with the therapeutical concentration of the drug in human plasma changed their discoid shape to both stomatocytes and echinocytes. Accord ing to the bilayer couple hypothesis, this means that adriamycin was incorporated into either the inner or outer leaflets of the erythrocyte membrane. To explain this unusual result, the drug was incubated with molecular models. One of them consisted o f dimyristoylphosphatidylcholine (DM PC) and dimyristoylphosphatidylethanolamine (D M P E ) multilayers, repre sentative of phospholipid classes located in the outer and inner leaflets o f the erythrocyte membrane, respectively. X-ray diffraction showed that adriamycin interaction perturbed the polar head and acyl chain regions of both lipids. Fluorescence spectroscopy on another model, consisting of DM PC large unilamellar vesicles (L U V ), confirmed the X-ray results in that adriamycin fluidized its hydrophobic moiety. It is concluded that adriamycin incorporates into both erythrocyte leaflets affecting its membrane structure.
Introduction
Adriamycin (doxorubicin) is an aminoglycosidic antibiotic of the anthracycline class widely used in the treatm ent of leukemias and solid tumors (Blum and Carter, 1979) . The mechanism of action has been generally based on its interaction with nuclear DNA through the intercalation of the ad riamycin planar ring between the base-pairs (Goormaghtigh et a l, 1990) . However, a growing body of evidence has challenged the dogma that it exerts the cytotoxic effect solely through interac tion with DNA. In fact, several reports increas ingly point to cellular membranes, and in particu lar the plasma membrane, as im portant structures involved in the mechanism of action of adriamycin (Tritton and Yee, 1982; Arancia et al., 1988; Garnier-Suillerot and Gattegno, 1988; Dupou-Cezanne et al., 1989; M arutaka et al., 1994; Speelmans et a l, 1996) . That the interactions with the cell sur face are essential for the antitum or activity of adri amycin has been shown by demonstration of cytotoxicity using a non-penetrating polymer im mobilized drug (Tritton and Yee, 1982) . It has also been reported that no m atter how much adria mycin is present inside the cell, there must also be extracellular drug available for membrane interac tion in order to initiate nuclear DNA damage and the cytotoxic cascade (Vichi and Tritton, 1992) . Its main route of entry into a cancer cell is passive diffusion across the plasma membrane of the un charged form of the drug, which is moderately li pophilic (de Wolf et a l, 1993) and is a weak base with a pKa of 8.3 (Speelmans et al., 1996) . Several properties and functions of plasma membranes seem to be m odulated by adriamycin, such as gly coprotein synthesis, phospholipid structure, trans port, expression of horm one receptors (Arancia et a l, 1988), fluidity (M arutaka et a l, 1994), mor-phology and ultrastructure (Arancia et al., 1995) . Adriamycin strongly interacts with lipids of bio logical membranes, especially cardiolipin, which is an anionic phospholipid present in cardiac m ito chondria (Goormaghtigh et al., 1990; Garnier-Suillerot and Gattegno, 1988; Dupou-Cezanne et al., 1989; Speelmans et al., 1996) . Marked differences have been found in the interaction of adriamycin with acidic and neutral lipids. Thus, binding of ad riamycin to cardiolipin should result in a complex including two stacked adriamycin molecules elec trostatically bound on the two anionic phosphate groups of cardiolipin (Goormaghhtigh et a l, 1990) , decreasing the acyl chain order of the lipid (de Wolf et a l, 1993). In contrast, it should not affect the order and mobility in membranes consisting of zwitterionic phospholipids, even at drug concen trations exceeding 10 mM (de Wolf et al., 1992) . However, it has been reported that adriamycin in teracts with phosphatidylcholine small unilamellar vesicles in which hydrophobic interactions predo minate between the dihydroanthraquinone moiety of the drug with the hydrocarbon region of the lipid, and between the aminoglycosyl group with lipid phosphates (Dupou-Cezanne et a l, 1989). Therefore, the objective of this work was to exam ine the binding site of adriamycin in the mem branes and the resulting structural perturbations induced by the drug. We have focused on the erythrocyte membrane and molecular models built up with phospholipid classes representative of those located in its outer and inner leaflets. These systems have been used in our laboratories to de termine membrane interaction and perturbing ef fects of several agents Suwalsky and Frias, 1993; Suwalsky and Villena, 1995) . Scanning electron microscopy was used to detect human erythrocyte shape changes induced by adriamycin. The models con sisted of dimyristoylphosphatidylcholine (DM PC) and dimyristoylphosphatidylethanolamine (DM PE) multilayers, representative of phospholipid classes located in the outer and inner monolayers of the human erythrocyte membrane, respectively (Devaux and Zachowsky, 1994) , and of DMPC large unilamellar vesicles (LUV). Adriamycin perturba tion of the DMPC and DMPE multilayer structure was determ ined by X-ray diffraction. Because of the amphipathic character of adriamycin and of both phospholipids, their interactions were as sayed in hydrophobic and aqueous media in a wide concentration range. The effect of adria mycin on the physical properties of the bilayer of DMPC large unilamellar vesicles was examined by evaluation of DPH steady state fluorescence an isotropy.
M aterials and Methods

Scanning electron microscope (SEM) studies on human erythrocytes
Blood samples taken from clinically healthy male adult donors by puncture of the ear lobe dis infected with 70% ethanol were incubated with adriamycin. Two drops of blood were collected in a plastic tube containing 1 ml of saline (0.9% NaCl) at 5 °C. This solution was used to prepare the following samples: a) control, by mixing 0.1 ml with 0.9 ml of saline, b) 40 m M adriamycin, by mix ing 0.1 ml with 0.9 ml of adriamycin in adequate concentration. This concentration was calculated to be about that present in plasma when it is thera peutically injected to humans (Goodman and Gil man, 1996) . These samples were incubated at 37 °C for one h. They were then fixed with glutaraldehyde, adding one drop of each sample to a tube containing 1 ml of 2.5% glutaraldehyde in sa line, reaching a final fixation concentration of about 2.4%. A fter resting overnight at 5 °C the fixed samples were directly placed on Al stubs, air dried at 37 °C for half to one h and gold coated for 3 min at 10"1 Torr in a sputter device (Edwards S150). The observations and photographic records were perform ed in an Etec Autoscan SEM.
X-ray diffraction analysis o f phospholipid multilayers
Synthetic DMPC (lot 80H-8371 A grade MW 677.9), DM PE (lot 13H-83681 A grade MW 635.9) and adriamycin.HC1 (lot 63H-0349 from Sigma and batch 6009B47F as a gift from Pharmacia & Upjohn, MW 580.0) were used without further pu rification. A bout 5 mg of each phospholipid were mixed with the corresponding weight of adria mycin in order to attain DMPC:adriamycin and DMPE:adriamycin powder mixtures in the molar ratios of 10:1, 5:1 and 1:1. Each mixture was dis solved in chloroform:methanol 3:1 v/v and left to dry. The recrystallized samples were placed in special glass capillaries 0.7 mm dia. They were dif fracted in Debye-Scherrer cameras of 114.6 mm dia and flat-plate cameras with 0.25 mm dia glass collimators provided with rotating devices. The same procedure was followed with samples of each phospholipid and adriamycin. The aqueous speci mens were prepared in 1 mm dia glass capillaries, mixing each phospholipid and adriamycin in the proportions described above. Each capillary was then filled with about 100 of distilled water. These specimens were X-ray diffracted 2 days af ter preparation in flat-plate cameras. Specimen-tofilm distances were 8 and 14 cm, standardized by sprinkling calcite powder on the capillary surface. Ni-filtered CuKa radiation from a Philips PW1140 X-ray generator was used. The relative reflection intensities were obtained from films by peak-integration in the microdensitometers Joyce-Loebl M KIIICS and BIO-RAD using the Molecular A n alyst/PC image software. No correction factors were applied. The experiments in water were per formed at 17 ± 2 °C, which is below the main tran sition tem perature of both DMPC and DMPE.
Fluorescence measurements on large unilamellar vesicles (LU V)
DM PC LUV suspended in water were prepared by extrusion of frozen and thawed multilamellar liposome suspension (final lipid concentration 0.5 m M ) through two stacked polycarbonate filters of 400 nm pore size (Nucleopore, Corning Costar Corp.) under nitrogen pressure at 10 °C over the lipid transition temperature. DPH and Laurdan were incorporated into LUV by addition of small aliquots of concentrated solutions of the probe in tetrahydrofuran and ethanol respectively to LUV suspensions and gently shaken for about 30 min. Fluorescence spectra and anisotropy m easure ments were respectively performed in a Spex Fluorolog and in a phase shift and modulation Greg-200 steady-state and time-resolved spectrofluorom eter (I. S. S.), both interfaced to computers. Soft ware from I. S. S. was used for data collection and analysis. M easurements of LUV suspensions were made at 18 °C in 10 mm path-length square quartz cuvettes. Sample tem perature was controlled by an external bath circulator (Cole Parm er) and m easured prior to and after each m easurement using a digital therm om eter (Omega). Anisotropy M ario Suwalsky et al. ■ The A nticancer D rug A driam ycin measurements were made in the "L" configuration using prism polarizers (Gian Thompson) in both exciting and emitting beams. The emission was measured across a high pass filter (Schott WG-420) with negligible fluorescence. Laurdan fluores cence spectral shifts were quantified through the General Polarization (GP) concept which was evaluated by G P=(Ib-Ir)/(Ib+Ir), where lb and Ir are the intensities at the blue and red edges of the emission spectrum, respectively. These intensities have been m easured at the emission wavelengths of 440 and 490 nm, which correspond to the emis sion maxima of Laurdan in the gel and liquid crys talline phases, respectively (Parasassi and Gratton, 1995) . Adriamycin was incorporated in LUV sus pensions by addition of small aliquots of a concen trated ethanol solution and incubated at 40 °C for ca. 15 min. Samples with probes, but without adri amycin showed no variation in the measured param eters during periods longer than those em ployed in the experiments. Blank subtraction was perform ed in all measurem ents using unlabelled samples without probes.
Results
Scanning electron m icroscopy (SEM) studies on human erythrocytes
SEM of red cells incubated with 40 m M adria mycin, which is about the plasma concentration when therapeutically injected to humans (G ood man and Gilman, 1996) , revealed abnormalities in their shapes. In contrast to the normal discoid erythrocyte profile (Fig. la) , about half of the adri amycin treated cells showed stomatocytic shapes while the other half were crenocytic, i.e., evagination and invagination of their faces, respectively (Fig. lb) . This effect was observed in all the as sayed samples and the extent of the shape alter ation was always the same. Similar results were obtained with 0.8 m M adriamycin.
X-ray studies on phospholipid multilayers
On account of the amphipathic nature of adria mycin, DMPC, and DM PE, the molecular interac tions of the drug with bilayers of both phospholip ids were assayed in hydrophobic and aqueous media. molar mixtures after interaction and recrystalliza tion from chloroform:methanol 3:1 v/v solutions. Analysis of these results indicated that the X-ray pattern of DMPC was affected by adriamycin. At a lipid:drug molar ratio of 10:1 adriamycin de creased DMPC reflection intensities; several of them disappeared, in particular those of 4.30 A, 4.13 A and 3.88 A, which were replaced by one of 4.2 A. The appearance of this reflection was indicative of the fluid state reached by the lipid bilayer; in fact, it arises from the fully extended acyl chains organized with rotational disorder in a hexagonal lattice. This reflection is normally at tained when DMPC is immersed in water below its main transition tem perature (23 °C) as can be observed in Fig. 2b . What is surprising is that this reflection was also observed in dry specimens. On the other hand, the 54.5 A bilayer width of DMPC gradually expanded with increasing proportions of adriamycin up to 56.6 A in their 1:1 molar ratio. However, no reflections from the drug were ob served in any of its mixtures. These results clearly indicated that adriamycin penetrated into the pho spholipid bilayer structure, perturbing its molecu lar arrangement at the polar head and acyl chain regions. Fig. 2b shows the results obtained after DMPC, adriamycin and their molar mixtures in the above mentioned ratios were immersed in an excess of distilled water. As may be observed, water changed the X-ray pattern of DMPC; its bilayer width expanded from 54.5 A when dry to 64.0 A and its reflections were reduced to only the first three orders of the bilayer width and the relatively intense reflection of 4.2 A. As before, increasing concentrations of adriamycin produced a gradual expansion of the bilayer width and a decrease of the phospholipid reflection intensities. These ef fects indicated that adriamycin in an aqueous m e dium was also able to penetrate and perturb the DM PC bilayer structure.
The results obtained after the interaction of DM PE with adriamycin in the hydrophobic m e dium are depicted in Fig. 2c . As reported else where , DM PE exhibits two polymorphic forms; one (L c^ has extended hy drocarbon chains parallel to the bilayer normal, its bilayer width being about 52 A. The other form (L c 2) has hydrocarbon chains tilted about 30 °C and a bilayer width of nearly 44 A. Adriamycin produced the following effects in DMPE: a) an Lc] to L c2 phase transition, and b) a marked decrease of the lipid reflection intensities. Fig. 2d shows the results of the adriamycin-DMPE interaction in water. The drug did not induce a phase transition in DM PE, which remained throughout in the form; however, it interacted with DMPE in such a way that at the 1:1 molar ratio only a scanty num ber of considerably weakened reflections re mained. These results implied a strong interaction of adriamycin with DMPE, equivalent to that ob served with DMPC. This was rather surprising in view of the fact that DMPE bilayers pack closer and tighter than those of DMPC, therefore being more difficult to penetrate and perturb (Suwal sky, 1988) .
Fluorescence measurements on D M P C large unilamellar vesicles (LU V )
The influence of adriamycin upon the structure of the phospholipid acyl chain hydrophobic core of DM PC LUV was determ ined by fluorescence spectroscopy. Increasing concentrations of the drug significantly decreased D PH fluorescence an isotropy (r) ( Table I ). This effect would result from the adriamycin-induced disorder of the acyl chain packing of DMPC, in agreem ent with the Xray diffraction observations. The effects of the drug upon the hydrophilic/hydrophobic interface of the lipid through Laurdan general polarization could not be determ ined due to the absorption of adriamycin in the spectral region of the m easure ment. 
Discussion
Several reports increasingly point to the in volvement of cell m embranes in the anticancer mechanism of action of adriamycin, a drug which apparently modulates m em brane properties and functions. Therefore, it was considered of interest to determ ine the m em brane adriamycin-binding sites and the resulting structural perturbations. For these purposes we focused our research on the erythrocyte membrane, which has been exten sively studied. This cell type lacks nuclear binding sites for anthracyclines and is, therefore, a useful model to investigate the interaction of adriamycin with cell membranes. Electron microscopy of hu man erythrocytes incubated with adriamycin re vealed that they changed their normal discoid shape to both echinocytes and stomatocytes. A c cording to the bilayer couple hypothesis (Sheetz and Singer, 1974) , the shape changes induced in red cells by amphiphiles are due to differential ex pansion of the two monolayers. Thus, echinocytes are observed when the added molecules penetrate into the outer monolayer, whereas stomatocytes are induced when they enter into the inner m ono layer. In order to explain this rather unusual re sult, i.e.. the simultaneous presence of echinocytes and stomatocytes, molecular models of the eryth rocyte membrane were exposed to adriamycin.
One model consisted of DMPC and DM PE multilayers, representative of phospholipid classes located in the outer and inner monolayers of the human erythrocyte membrane, respectively (Devaux and Zachowsky, 1994) . X-ray studies showed that adriamycin strongly interacted with both. This result, which implies that adriamycin is able to in sert into the outer as well as in the inner lipid monolayers of the erythrocyte membrane, cer tainly might explain the erythrocytes shape changes. The membrane distribution of the drug is confirmed by kinetic studies, which have dem on strated the existence of two similar sized pools of adriamycin in the two leaflets of the erythrocyte m embrane (Regev and Eytan, 1997) . Although the interaction of the drug with membrane proteins can not be ruled out, our results indicate that adri amycin interacts with membranes by incorpora tion into lipid bilayers. Analysis of the X-ray dif fraction experiments on DMPC and DM PE bilayers and those performed by fluorescence spectroscopy on DMPC LUV indicate that their polar head and the hydrophobic acyl chain regions were perturbed by adriamycin. This means that the drug interacts with the bilayers in such a way that part of the molecule incorporates into the hy drocarbon chains and another part is in contact with the polar groups. This conclusion agrees with experimental data reported in the literature (Garnier-Suillerot and Gattegno, 1988; Dupou-Cezanne et al., 1989; Giuliani et al., 1988) . Thus, the dihydroanthraquinone residue of adriamycin could be bound through hydrophobic interactions with the lipid acyl chains, whereas the ammonium group of the drug could be electrostatically bound to the negatively charged phosphates.
To conclude, our observations indicate that adri amycin interacts with the cell membrane by its in corporation into both lipid monolayers. This ac tion should modify cell membrane structure and physiological properties, such as fluidity, perm e ability, receptor and channel functions, and so on. Thus, the cytotoxic action of adriamycin might be mediated by its interaction with cell membranes. For instance, it has been reported that the ability of adriamycin to modulate the sensitivity of target cells for destruction by immune effectors is due to membrane alterations resulting from direct actions of the drug (M arutaka et al., 1994) .
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